Cancer Immunotherapy

The Association for Cancer Immunotherapy CIMT is a member-based information and education platform promoting the development of cancer immunotherapies.

[Guezguez lab @GuezguezL]

🔥 A key question in #CHIP: why do some mutant HSC clones expand while others remain constrained?

🎯 In a new study in @BloodJournal, Lee et al. (@SC_Allison_Yeh) provide a compelling answer: the BM niche in CHIP is a mosaic of “hot” and “cold” cavities, where macrophage-driven remodeling shapes Tet2 HSC clonal fitness.

I had the opportunity to write a commentary discussing the broader implications of this work:
👉 Commentary: https://t.co/dJTDQMj8qt
👉 Original study: https://t.co/XrKsngUEXg
@ASH_hematology

[Guezguez lab @GuezguezL]

🚨 Excited to share our new study in Nature Communications!
We show how chronic inflammation rewires the human bone-marrow microenvironment long before leukaemia develops.

👉 https://t.co/O74Hh1mRDS

[Cancer Immunotherapy @C_IMT]

Catch us on Bluesky: @cimt.bsky.social

[Guezguez lab @GuezguezL]

🌟 Thank you to @IRCM_MTP @adjiane for the warm invitation to visit your institute and showcase our work in #leukemia #microenvionment and #epigenetictherapy. Excited to share ideas and engage with such a vibrant scientific community and potential collaborations. Merci! 🇫🇷 💊👨‍🔬

[Cancer Immunotherapy @C_IMT]

CIMT Summer School is in full swing here at the beautiful Castelo de Palmela, Portugal with lectures, flash talks and posters on cellular cancer immunotherapies. A big thank you to our partner, the Champalimaud Foundation @ChampalimaudF for their support in making this possible.

[Cancer Research Institute @CancerResearch]

The fourth day of #CICON24 concluded the conference with a half-day of intense focus on the future of cancer care and treatment! Explore research shared during the event's ninth session, and more, in today's recap blog: https://t.co/aJKnOBoHpg #CancerResearch #CancerVaccines

[Cancer Research Institute @CancerResearch]

To young researchers at #CICON24 who are navigating their futures in the field of cancer research, @MSKCancerCenter's Dr. Dana Pe'er emphasizes, "You need to follow your passion, because passion drives ideas. Passion drives innovation." #CancerResearch #Immunotherapy

[Cancer Research Institute @CancerResearch]

During an exclusive interview from the second day of #CICON24, Dr. Andrew Koh from @UTSWMedCenter describes what excites him most about the current state of cancer immunotherapy! #Immunotherapy #CancerResearch

[Cancer Research Institute @CancerResearch]

Discover the groundbreaking research and collaboration that's driving the future of cancer immunotherapy, in our daily recap blog from the first day of #CICON24, presented by CRI and @ENCI_network, in conjunction with @C_IMT, EATI, NIBIT, and GÉTICA: https://t.co/WizDnKDnWh

[Max @MaxKrummel]

Interested in the evolution of how we share and curate our science? For those coming to CICON24, check out @beiyun_liu and this poster. For those not there, try this out, participate, enjoy helping science and your colleagues move forward: https://t.co/KOflhzoJw9

[Cancer Research Institute @CancerResearch]

The Eighth International Cancer Immunotherapy Conference kicks off this morning! Joining the Cancer Research Institute and @ENCI_network in National Harbor, MD today? Share your own photos and content from the conference, using the hashtag #CICON24 to be reposted!

[Cancer Immunotherapy @C_IMT]

Join us in beautiful Lisbon to explore cellular therapies for solid tumors. Academic researchers attend for free. Don’t miss this unique opportunity to engage with leading experts and pioneers in the field. https://t.co/0I9z0SUkAQ

[ACIR @ACIR_org]

Register before July 15 to get the early-bird discount 🐦 #CICON24

[Guezguez lab @GuezguezL]

Thank you @TheBinderLab and Marieke Essers @hi_stem_lab for organizing this fantastic #interferon Symposium 👏🏻👏🏻 great opportunity to present our work and build up new connections, I learned a lot! ✍️🧬🔬

[[email protected] @ClaudioTripodo]

Mark your calendars! Join us in Palermo October 17-19, 2024, for the XXI NIBIT Meeting. Connect with leading minds, share insights, and explore new horizons in cancer immunology and immunotherapy. Don't miss out! #NIBIT2024

[Cancer Research Institute @CancerResearch]

Register by July 15, and save with early-bird discounts for #CICON24, presented by CRI and @ENCI_network, in conjunction with ENCI partner organizations, @C_IMT, EATI, NIBIT, and GÉTICA! Sign up to attend the conference, held from September 8-11, 2024: https://t.co/Ilq7Z3uGXn

[Cancer Immunotherapy @C_IMT]

Are you a PhD student or postdoc with a research focus in cellular immunotherapies? Apply by June 14 to present your work, connect with peers and scientific leaders in an extraordinary retreat setting in Portugal. https://t.co/pywvq3UXEZ

[Majzner_Lab @Majzner_Lab]

Recruitment! We are looking for a candidate for the lab (postdoc or scientist) with experience in yeast and/or phage display to work on some cool bioengineering projects for immunotherapy development! Please reach out if interested! Science friends, please retweet!

[Cancer Immunotherapy @C_IMT]

Last session #CIMT2024: fascinating impact of #immunometabolism in reshaping tumor #microenvionment and enhancing #therapy of tissue-resident memory T-cells (@MReinaCampos @ljiresearch) #TAM macrophages (@JennGuerriero @DanaFarber) and CD8+ reprogramming (Jin Chen @UChicagoMed)

[Cancer Immunotherapy @C_IMT]

#CIMT2024 Session Focus on #Africa highlighting the fantastic effort by @NCIGopal @NCIGlobalHealth @theNCI and @DrNyongesa @catherinenyonge in delivering affordable cost effective cancer treatment and #Immunotherapy-based Healthcare #care #equality #clinicaltrial 💊🔬👏👏